New
Arrivals/Restock
Respiratory Test Kit LumiraDx™ SARS-CoV-2 Ag 48 Tests CLIA Waived
5.0 (61 items)
Limited Time SaleUntil the end
04
27
49
$416.76 cheaper than the new price!!
Free shipping for purchases over $99 ( Details )
Free cash-on-delivery fees for purchases over $99
Free cash-on-delivery fees for purchases over $99
See all stores
Please note that the sales price and tax displayed may differ between online and in-store. Also, the product may be out of stock in-store.
New $833.52
Product details
| Management number | 203184412 | Release Date | 2025/09/22 | List Price | $416.76 | Model Number | 203184412 | ||
|---|---|---|---|---|---|---|---|---|---|
| Category | |||||||||
- Results in 12 minutes
- Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen; antigen is generally detectable in nasal swab specimens during the acute phase of infection.
- The LumiraDx SARS-CoV-2 Ag test does not differentiate between SARS-CoV and SARS-CoV-2.
- Rapid microfluidic immunofluorescence assay test method
- LumiraDx SARS-CoV-2 Ag Test is for use under an Emergency Use Authorization only.
- Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C 263a, that meet the requirements to perform moderate, high or waived complexity tests.
- Test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.
- LumiraDx SARS-CoV-2 Ag Test is intended for use by trained clinical laboratory personnel and individuals trained in point of care settings, and proficient in performing tests using the LumiraDx Instrument.
- 48 tests
Lab Supplies
Button down shirt
Correction of product information
If you notice any omissions or errors in the product information on this page, please use the correction request form below.
Correction Request Form